MammoScreen Breast Cancer Risk Assessment and Decision Aid for Breast Cancer Screening and Referrals
For patients and families
In plain language
An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.
- What is being studied
- The protocol lists: Electronic Health Record Review, Interview, Media Intervention, Survey Administration.
- Who it may be relevant to
- Registry conditions: Breast Carcinoma. Basic parameters: 40 years — 74 years · Female.
- What needs checking
- Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
- Where it takes place
- United States
- Next step
- Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →
Unsure about the terms? Read our patient guide →
Official title
Implementing USPSTF Recommendations for Breast Cancer Screening and Prevention by Integrating Clinical Decision Support Tools With the Electronic Health Record
Overview
This study collects information to implement MammoScreen for Breast Cancer Screening and Referrals. MammoScreen is a risk assessment questionnaire that identifies individuals at average and increased risk for breast cancer and guides their screening decisions.
Detailed description
PRIMARY OBJECTIVES:
I. Uptake of MammoScreen (the proportion of women who enroll and use MammoScreen, also referred to as Reach.
II. Identification of women with above-average risk for breast cancer by MammoScreen integrated with the electronic health record (EHR).
SECONDARY OUTCOMES:
I. Rates of mammography screening referral. II. Screening completed and mammography results stratified by risk category. III. Among those who meet criteria, genetic counseling referral, visit completed and genetic test done.
OUTLINE:
CLINICAL STAFF: During development some clinical team members will participate in usability testing (up to 30 minutes) of the electronic health record interface with MammoScreen. Some participants will undergo training sessions of about 20 minutes, then participate in interviews lasting up to 30 minutes at baseline prior to MammoScreen launch. Clinical staff also participate in interviews up to 30 minutes after MammoScreen launch during years 2-4. Participants complete surveys during the maintenance phase about six months after the last reminders are sent.
PATIENTS: Patients (enrolled from OHSU IMC) participate in interviews lasting up to 1 hour. Patients medical records are reviewed. Patients will be invited via MyChart to use the MammoScreen. Reminders will be sent via MyChart to non-respondents at 2 and 4 weeks. Patients will use MammoScreen one time right after enrollment. Some patients may also participate in interviews up to 1 hour each during years 3-5.
Interventions
- Other Electronic Health Record Review
Health record reviewed - Other Interview
Participate in interview - Other Media Intervention
Use MammoScreen - Other Survey Administration
Complete survey - Other Training and Education
Undergo training
Primary outcome measures
- Uptake of MammoScreen [Time frame: Up to 5 years]
- Number of women with above-average risk for breast cancer identified by MammoScreen integrated with the electronic health record [Time frame: Up to 5 years]
Secondary outcome measures (6)
- Rates of mammography screening referral [Time frame: Up to 5 years]
- Screening completed [Time frame: Up to 5 years]
- Mammography results [Time frame: Up to 5 years]
- Number of above average risk MammoScreen users who received a genetic counseling referral [Time frame: Up to 5 years]
- Number of above average risk MammoScreen users who completed a genetic counseling visit [Time frame: Up to 5 years]
- Number of above average risk MammoScreen users who had a genetic test done [Time frame: Up to 5 years]
Eligibility criteria
Inclusion criteria
- Women between the ages of 40 and 74
- Enrolled in MyChart
- Able to read English
Exclusion criteria
- Personal history of breast or ovarian cancer
- Currently Pregnant
- Currently in Hospice
Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.
Healthy volunteers: Yes
Study design
- Observational model
- Other
Study locations
United States · 1 center
- OHSU Knight Cancer Institute — Portland
Identifiers
NCT: NCT04996316 · STUDY00022698 · NCI-2021-06583 · STUDY00022698 · R01HS027796